There were 30 million people living with cancer in 2015. The document discusses various treatment options for cancer including surgery, radiation therapy, hormone therapy, chemotherapy, targeted therapy, and immunotherapy. It notes that there are already multiple biological agents available for non-small cell lung cancer treatment. Only a fraction of molecular aberrations are clinically relevant for cancer treatment.

10. 30 million ptes living with cancer 2015
CA&C: 255,900 CASES
173
134

12. OPCIONES DE TRATAMIENTO
• 1) Cirugía
• 2) Radioterapia
• 3) Hormonoterapia
• 4) Quimioterapia
• 5)Terapia Blanco
• 6) Inmunoterapia……

13. Tratamiento
Blanco
Biologico

14. There Are Multiple Agents Already Available

17. Non-small-cell lung cancer (NSCLC)
Presented By Daniel Costa at 2014 ASCO Annual Meeting

20. Only a fraction of molecular aberrations are clinically relevant
Presented By David Gerber at 2014 ASCO Annual Meeting

37. Figure 1
Immunity 2013 39, 1-10DOI: (10.1016/j.immuni.2013.07.012)
Copyright © 2013 Elsevier Inc. Terms and Conditions

38. Figure 2
Immunity 2013 39, 1-10DOI: (10.1016/j.immuni.2013.07.012)
Copyright © 2013 Elsevier Inc. Terms and Conditions

39. Figure 3
Immunity 2013 39, 1-10DOI: (10.1016/j.immuni.2013.07.012)
Copyright © 2013 Elsevier Inc. Terms and Conditions